Iron Deficiency Anaemia: Managing symptoms and supporting selfcare. (2024)
This handbook provides pharmacists with the latest insights into iron deficiency anaemia, drawing on collective evidence and recommendations from existing guidelines and expert consensus. It addresses not only pharmacological treatment and non-pharmacological interventions but also prevention strategies. Additionally, the handbook covers guidelines for managing iron deficiency anaemia (IDA) in special populations, including paediatrics, non-pregnant women of reproductive age, pregnant women and breastfeeding mothers, the elderly, patients with chronic diseases, and individuals on strict diets. Overall, this handbook serves as an invaluable resource for pharmacists in managing IDA, underpinning the importance of pharmacists’ role in screening, managing, treating, patient education, and holistic self-care practices.
Pharmacy-based point-of-care testing: A global intelligence report. (2023)
“Pharmacy-based point-of-care testing: A global intelligence report” brings together evidence from a literature review, findings from a survey of 25 countries, 11 case studies, and the discussion of a FIP insight board, giving an overview of pharmacist-led POCT interventions around the world.POCT services, which include a wide range of tests to identify, diagnose, assess and/or monitor indicators of health, are strongly correlated with positive health outcomes. They are also linked to economic savings, increased health system efficiency and reduced burden on other healthcare sectors, the authors say. The report gives examples of POCT services being linked to prescribing authority by pharmacists, contributing to reducing pressure on general practice and emergency departments.
This document is available in:
Medication review and medicines use review. A toolkit for pharmacists (2022)
This current toolkit is an update to the version of the toolkit on MUR published in December 2020. This new
version frames MUR as a subtype of MR, defines each type of professional service and provides guidance on
their implementation. Although it could seem that the difference between both services is subtle and mostly
terminological, there is a significant conceptual difference between MR — a service where the healthcare
team assesses a patient’s current medicines to optimise clinical, humanistic and economic factors—and MUR,
where the emphasis is in the word “use”, and where pharmacists interact directly with patients to improve
their medicines use, considering their preferences and, ultimately, optimising adherence to treatment
Medicines reconciliation: a toolkit for pharmacists (2021)
This toolkit summarises the definitions, impact, and procedures for the implementation of pharmacist-led
medicines reconciliation in both community-based and hospital health care settings, with a set of tools to support this practice
Medicines use review: a toolkit for pharmacists (2020)
This toolkit serves as a practical reference guide to implementing and conducting optimal MUR. It includes service implementation tools which can be directly used or adapted for clinical practice at the patient level.
Beating non-communicable diseases in the community: The contribution of pharmacists (2019)
This reference paper provides global evidence to advocate, nationally and internationally, for an expanded role for pharmacists in NCD management by compiling best practices and examples. It also encourages pharmacists around the world to act upon NCDs.
The role of pharmacists in non-communicable diseases (2019)
This FIP statement of policy renews the commitment of the profession to the optimal prevention, detection and care of patients living with NCDs. It replaces the 2006 FIP Policy Statement on the role of the pharmacist in the prevention and treatment of chronic diseases.
Use of medicines by the elderly: The role of pharmacy in promoting adherence (2018)
This report explores the role of pharmacy in promoting medicine adherence among the elderly. It showcases best practices, interventions and programmes initiated around the world to improve medication adherence, particularly those targeting the elderly.
How pharmacists can improve adherence in the elderly (2018)
Article published on the International Pharmacy Journal.
The role of the pharmacist in the prevention and treatment of chronic disease (2006)
This FIP statement of policy served as the first response of the Federation that highlights the role of pharmacists in addressing and managing chronic diseases.
The Role of the Pharmacist in Encouraging Adherence to Long-term Treatments (2003)
This statement of professional standards encourages pharmacists providing services involving long-term treatment with medicines to assist patients to improve adherence.
